Skip to Content

Keytruda Prices, Coupons and Patient Assistance Programs

Keytruda (pembrolizumab) is a member of the anti-PD-1 monoclonal antibodies drug class and is commonly used for Breast Cancer, Cervical Cancer, Colorectal Cancer, and others.

Keytruda Prices

The cost for Keytruda intravenous solution (25 mg/mL) is around $5,265 for a supply of 4 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Keytruda price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Intravenous Solution

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Keytruda Coupons and Rebates

Keytruda offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Keytruda Merck Co-Pay Assistance Program: Eligible commercially insured patients pay $0 per infusion with a maximum benefit of $25,000 per calendar year; for additional information contact the program at 855-257-3932.

Applies to:
Keytruda
Number of uses:
per prescription per calendar year
Expires
September 30, 2021

Form more information phone: 855-257-3932 or Visit website

Patient Assistance Programs for Keytruda

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: HealthWell Foundation Copay Program

Elligibility requirements:
  1. May have insurance
  2. Varies
  3. FDA Approved Diagnosis - See Program Website for Details
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Keytruda (pembrolizumab) Injection; IV

More information please phone: 800-675-8416 Visit Website

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Keytruda (pembrolizumab) Injection; IV

More information please phone: 866-316-7263 Visit Website

Provider: Merck Access Program for Keytruda

Elligibility requirements:
  1. Determined case by case
  2. Not disclosed
  3. Medically appropriate condition/diagnosis
  4. Must be residing in the US or a US territory, and under the care of a US physician
  5. Patient must sign the enrollment form to give the program permission to access their financial information in order to determine eligibility. Patients in need who appear not to qualify should still call. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Keytruda (pembrolizumab) Injection; IV

More information please phone: 855-257-3932 Visit Website